7:45 – 8:30 am
General Check-in & Networking Breakfast
Sponsored by:
8:30 – 8:45 am
Welcome & Chairman’s 2016 Year in Review
Emmett T. Cunningham Jr., MD, PhD, MPH , Partner – Clarus
8:45 – 10:30 am
Anterior Segment Company Showcase
Co-Moderated By:
Christy Shaffer, PhD , General Partner – Hatteras Venture Partners
Catherine Truitt , Head, Search and Evaluation – Alcon
Company Presentations
8:45 – 8:52 | Avedro | Rajesh K. Rajpal, MD , Chief Medical Officer
8:52 – 8:59 | Z Lens | Paul Beer, MD , Founder & CEO
8:59 – 9:06 | PowerVision | Barry Cheskin , Co-Founder, President & CEO
9:06 – 9:13 | Novaliq GmbH | Bernhard Günther , CEO & Managing Director
9:13 – 9:20 | Mynosys Cellular Devices | John Hendrick , President & CEO
9:20 – 9:27 | ReVision Optics | John Kilcoyne , President & CEO
9:27 – 9:34 | AcuFocus | Al Waterhouse , President
9:34 – 9:41 | Encore Vision | Bill Burns , President & CEO
9:41 – 9:48 | Mati Therapeutics | Bob Butchofsky , Founder & CEO
9:48 – 9:55 | Envisia Therapeutics | Benjamin Yerxa, PhD , President
9:55 – 10:02 | Ivantis | Dave Van Meter , President & CEO
10:02 – 10:09 | Sensimed AG | David Bailey , CEO
10:09 – 10:16 | TearScience | Joseph Boorady , President & CEO
10:16 – 10:23 | LacriScience | Chris Geddes, PhD , Chief Biomedical/Plasmonics Consultant
10:23 – 10:30 | SightLife | Monty Montoya , CEO
10:30 – 11:00 am
Morning Networking & Refreshment Break
Sponsored by:
11:00 am – 12:38 pm
Posterior Segment Company Showcase
Co-Moderated By:
Peggy Hawkins , Business Development & Venture Management – Santen
Tom Cordaro , Head, Ophthalmology Pipeline – Bayer
Company Presentations
11:00 – 11:07 | Aura Biosciences | Elisabet de los Pinos , CEO
11:07 – 11:14 | AGTC | Sue Washer , President & CEO
11:14 – 11:21 | Clearside Biomedical | Daniel White , President & CEO
11:21 – 11:28 | Alimera Sciences | Dan Myers , CEO
11:28 – 11:35 | Aerpio Therapeutics | Joseph Gardner , President & CEO
11:35 – 11:42 | Allegro Ophthalmics | Vicken Karageozian, MD , President & Chief Medical Officer
11:42 – 11:49 | Ocular Therapeutix | Amar Sawhney, PhD , President, CEO & Chairman
11:49 – 11:56 | Graybug Vision | Jeffrey Cleland, PhD , President & CEO
11:56 – 12:03 | PanOptica | Paul Chaney , Co-Founder, President & CEO
12:03 – 12:10 | Opthea | Megan Baldwin, PhD , CEO & Managing Director
12:10 – 12:17 | Ohr Pharmaceutical | Jason Slakter , CEO
12:17 – 12:24 | Tracery Ophthalmics inc | Shelley Boyd, MD , President & CEO
12:24 – 12:31 | Apellis Pharmaceuticals | Cedric Francois, MD, PhD , CEO
12:31 – 12:38 | Notal Vision | Quinton Oswald , CEO
12:38 – 12:43 pm
Private Funding Trends Presentation
Jonathan Norris , Managing Director – SVB
12:43 – 1:25 pm
Networking Lunch
Sponsored by:
1:25 – 1:50 pm
OIS Industry Tribute to Allergan
Interviewed By:
William J. Link, PhD , Managing Director – Versant Ventures
Award Recipients:
Gavin Herbert , Founder
David Pyott , Former CEO
1:50 – 2:20 pm
BUILDING A GLOBAL OPHTHALMIC FRANCHISE
Moderated By:
Emmett T. Cunningham Jr., MD, PhD, MPH , Partner – Clarus
Participants:
Robert Dempsey , Franchise Head, Ophthalmics – Shire
Jerry St. Peter , VP & Head, Sun Ophthalmics – Sun Pharmaceutical Industries
Ashley McEvoy , Company Group Chairman – Johnson & Johnson Vision Care
Calvin Roberts, MD , SVP & Chief Medical Officer – Bausch + Lomb
Jim Mazzo , Global President Ophthalmic Devices – Carl Zeiss Meditec
2:20 – 2:50 pm
Afternoon Networking & Refreshment Break
Sponsored by:
2:50 – 2:55 pm
Ophthalmic Innovation 2016 – “A View from the AAO”
David Parke, II, MD , CEO – American Academy of Ophthalmology (AAO)
2:55 – 3:00 pm
Ophthalmic Innovation 2016 – “A View from the NEI”
Mala Dutta, PhD , Lead, Office of Translational Research, National Eye Institute – NIH
3:00 – 3:05 pm
A View of the Public Ophthalmology Market & Exit Trends
Joe Gilliam , Managing Director, Healthcare Investment Banking – J.P. Morgan Securities
3:05 – 3:10 pm
Introduction of the OIS Index
Michael Lachman , Founder – EyeQ Research
3:10 – 3:58 pm
Public Device & BioPharma Ophthalmology Company Showcase
Moderated By:
Tom Salemi , Content Director – Healthegy
Company Presentations
3:10 – 3:18 | Aerie Pharmaceuticals | Vicente Anido Jr., PhD , CEO & Chairman
3:18 – 3:26 | Inotek Pharmaceuticals | David Southwell , President & CEO
3:26 – 3:34 | QLT | David Saperstein, MD , Chief Medical Advisor
3:34 – 3:42 | Adverum Biotechnologies | Samuel B. Barone, MD , SVP, Clinical Development
3:42 – 3:50 | pSivida | Nancy Lurker , President & CEO
3:50 – 3:58 | Omeros | Leonard M. Blum , Chief Business & Commercial Officer
3:58 – 4:30 pm
Innovative Financing Options in Ophthalmology
Moderated By:
Gilbert H. Kliman, MD , Managing Director – InterWest Partners
Participants:
Sean Ianchulev, MD, MPH , Clinical Associate Professor – UCSF
Laurent Attias , Head of Strategy, BD&L and M&A – Alcon
Nir Ellenbogen , Managing Director – Eye-Lens Pte Ltd
Jeffry Weinhuff , Managing Partner – Visionary Venture Fund
Patricia Zilliox, PhD , Chief Drug Development Officer – Foundation Fighting Blindness
4:30 – 5:10 pm
Masters of the Industry
Moderated By:
Jim Mazzo , Global President Ophthalmic Devices – Carl Zeiss Meditec
Participants:
Flemming Ornskov, MD , CEO – Shire
Mike Ball , CEO – Alcon
Ashley McEvoy , Company Group Chairman – Johnson & Johnson Vision Care
William J. Link, PhD , Managing Director – Versant Ventures
Ludwin Monz, PhD , President & CEO – Carl Zeiss Meditec
William Meury , Chief Commercial Officer – Allergan
5:10 – 5:15 pm
Closing Remarks
William J. Link, PhD , Managing Director – Versant Ventures
5:15 – 6:15 pm
Networking Reception
Sponsored by: